{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:20:09Z","timestamp":1790382009821,"version":"4.1.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI052066"],"award-info":[{"award-number":["T32 AI052066"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NIH R01 AI145428, AI108404 and AI134220"],"award-info":[{"award-number":["NIH R01 AI145428, AI108404 and AI134220"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NIH R01 AI145428, AI108404 and AI134220"],"award-info":[{"award-number":["NIH R01 AI145428, AI108404 and AI134220"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["T32 TR004367"],"award-info":[{"award-number":["T32 TR004367"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Colorado ASPIRE Program"},{"name":"University of Colorado RNA Bioscience Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"DOI":"10.1007\/s11904-026-00773-4","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:47:05Z","timestamp":1771220825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cytotoxic CD4 T Cells: Dual Agents in HIV-1 Pathogenesis and Persistence"],"prefix":"10.1007","volume":"23","author":[{"given":"Kaylee L.","family":"Mickens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario L.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00194","volume":"8","author":"A Takeuchi","year":"2017","unstructured":"Takeuchi A, Saito T. CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function. Front Immunol. 2017;8:194. https:\/\/doi.org\/10.3389\/fimmu.2017.00194.","journal-title":"Front Immunol"},{"key":"773_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271236","volume":"14","author":"A Malyshkina","year":"2023","unstructured":"Malyshkina A, Bruggemann A, Paschen A, Dittmer U. Cytotoxic CD4(+) T cells in chronic viral infections and cancer. Front Immunol. 2023;14:1271236. https:\/\/doi.org\/10.3389\/fimmu.2023.1271236.","journal-title":"Front Immunol"},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"867189","DOI":"10.3389\/fimmu.2022.867189","volume":"13","author":"M Cenerenti","year":"2022","unstructured":"Cenerenti M, Saillard M, Romero P, Jandus C. The era of cytotoxic CD4 T cells. Front Immunol. 2022;13:867189. Epub 20220427. doi: 10.3389\/fimmu.2022.867189. PubMed PMID: 35572552; PubMed Central PMCID: PMCPMC9094409.","journal-title":"Front Immunol"},{"key":"773_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951900","volume":"13","author":"C Hoeks","year":"2022","unstructured":"Hoeks C, Duran G, Hellings N, Broux B. When helpers go above and beyond: development and characterization of cytotoxic CD4. Front Immunol. 2022;13:951900. https:\/\/doi.org\/10.3389\/fimmu.2022.951900.","journal-title":"Front Immunol"},{"key":"773_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.05.001","volume":"247","author":"T Preglej","year":"2022","unstructured":"Preglej T, Ellmeier W. CD4. Immunol Lett. 2022;247:27\u201342. https:\/\/doi.org\/10.1016\/j.imlet.2022.05.001.","journal-title":"Immunol Lett"},{"key":"773_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00019","volume":"8","author":"JA Juno","year":"2017","unstructured":"Juno JA, van Bockel D, Kent SJ, Kelleher AD, Zaunders JJ, Munier CM. Cytotoxic CD4 T cells-friend or foe during viral infection? Front Immunol. 2017;8:19. https:\/\/doi.org\/10.3389\/fimmu.2017.00019.","journal-title":"Front Immunol"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcv.2019.08.004","volume":"119","author":"A Sanchez-Martinez","year":"2019","unstructured":"Sanchez-Martinez A, Perdomo-Celis F, Acevedo-Saenz L, Rugeles MT, Velilla PA. Cytotoxic CD4. J Clin Virol. 2019;119:17\u201323. https:\/\/doi.org\/10.1016\/j.jcv.2019.08.004.","journal-title":"J Clin Virol"},{"issue":"12","key":"773_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/erv.10.132","volume":"9","author":"DZ Soghoian","year":"2010","unstructured":"Soghoian DZ, Streeck H. Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines. 2010;9(12):1453\u201363. https:\/\/doi.org\/10.1586\/erv.10.132.","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"773_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.molmed.2012.09","volume":"18","author":"PR Hiebert","year":"2012","unstructured":"Hiebert PR, Granville DJ. Granzyme B in injury, inflammation, and repair. Trends Mol Med. 2012;18(12):732\u201341. https:\/\/doi.org\/10.1016\/j.molmed.2012.09. Epub 20121022.","journal-title":"Trends Mol Med"},{"key":"773_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031833","author":"ZLZ Hay","year":"2022","unstructured":"Hay ZLZ, Slansky JE. Granzymes: the molecular executors of immune-mediated cytotoxicity. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031833.","journal-title":"Int J Mol Sci"},{"issue":"42","key":"773_CR11","doi-asserted-by":"publisher","first-page":"27364","DOI":"10.1074\/jbc.273.42.27364","volume":"273","author":"JL Harris","year":"1998","unstructured":"Harris JL, Peterson EP, Hudig D, Thornberry NA, Craik CS. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem. 1998;273(42):27364\u201373. https:\/\/doi.org\/10.1074\/jbc.273.42.27364. PubMed PMID: 9765264.","journal-title":"J Biol Chem"},{"key":"773_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev.immunol.26.021607.090404","volume":"26","author":"D Chowdhury","year":"2008","unstructured":"Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol. 2008;26:389\u2013420. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090404. PubMed PMID: 18304003; PubMed Central PMCID: PMCPMC2790083.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"773_CR13","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1128\/JVI.68","volume":"68","author":"P Borrow","year":"1994","unstructured":"Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8\u2009+\u2009cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68(9):6103\u201310. https:\/\/doi.org\/10.1128\/JVI.68. PubMed PMID: 8057491; PubMed Central PMCID: PMCPMC237022.","journal-title":"J Virol"},{"issue":"7","key":"773_CR14","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1128\/JVI.68","volume":"68","author":"RA Koup","year":"1994","unstructured":"Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68(7):4650\u20135. https:\/\/doi.org\/10.1128\/JVI.68. PubMed PMID: 8207839; PubMed Central PMCID: PMCPMC236393.","journal-title":"J Virol"},{"issue":"2","key":"773_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.193.2.181","volume":"193","author":"PJ Goulder","year":"2001","unstructured":"Goulder PJ, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, Eldridge RL, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med. 2001;193(2):181\u201394. PubMed PMID: 11148222; PubMed Central PMCID: PMCPMC2193346.","journal-title":"J Exp Med"},{"issue":"4783","key":"773_CR16","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1126\/science.2431484","volume":"234","author":"CM Walker","year":"1986","unstructured":"Walker CM, Moody DJ, Stites DP, Levy JA. CD8\u2009+\u2009lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986;234(4783):1563\u20136. https:\/\/doi.org\/10.1126\/science.2431484. PubMed PMID: 2431484.","journal-title":"Science"},{"issue":"20","key":"773_CR17","doi-asserted-by":"publisher","first-page":"9771","DOI":"10.1128\/Jvi.75.20.9771-9779.2001","volume":"75","author":"PJ Norris","year":"2001","unstructured":"Norris PJ, Sumaroka M, Brander C, Moffett HF, Boswell SL, Nguyen T, et al. Multiple effector functions mediated by human immunodeficiency virus-specific CD4\u2009+\u2009T-cell clones. J Virol. 2001;75(20):9771\u20139. https:\/\/doi.org\/10.1128\/Jvi.75.20.9771-9779.2001. PubMed PMID: WOS:000171102900024.","journal-title":"J Virol"},{"issue":"7","key":"773_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00002030-199207000-00005","volume":"6","author":"SK Kundu","year":"1992","unstructured":"Kundu SK, Merigan TC. Equivalent recognition of HIV proteins, Env, gag and Pol, by CD4\u2009+\u2009and CD8\u2009+\u2009cytotoxic T-lymphocytes. AIDS. 1992;6(7):643\u20139. PubMed PMID: 1354446.","journal-title":"AIDS"},{"issue":"1","key":"773_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/infdis\/174.1.209","volume":"174","author":"M Heinkelein","year":"1996","unstructured":"Heinkelein M, Euler-Konig I, Klinker H, Ruckle-Lanz H, Jassoy C. Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo. J Infect Dis. 1996;174(1):209\u201313. https:\/\/doi.org\/10.1093\/infdis\/174.1.209.","journal-title":"J Infect Dis"},{"issue":"15","key":"773_CR20","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1128\/JVI.00513-09","volume":"83","author":"N Zheng","year":"2009","unstructured":"Zheng N, Fujiwara M, Ueno T, Oka S, Takiguchi M. Strong ability of Nef-specific CD4\u2009+\u2009cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4\u2009+\u2009T cells and macrophages. J Virol. 2009;83(15):7668\u201377. https:\/\/doi.org\/10.1128\/JVI.00513-09.","journal-title":"J Virol"},{"issue":"5","key":"773_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1020066404226","volume":"22","author":"B Lotti","year":"2002","unstructured":"Lotti B, Wendland T, Furrer H, Yawalkar N, Greyerz SV, Schnyder K, et al. Cytotoxic HIV-1 p55gag-specific CD4\u2009+\u2009T cells produce HIV-inhibitory cytokines and chemokines. J Clin Immunol. 2002;22(5):253\u201362. \/02\/0900\/0253\/0. PubMed PMID: WOS:000177628900001.","journal-title":"J Clin Immunol"},{"issue":"16","key":"773_CR22","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.1128\/Jvi.78.16.8844-8851.2004","volume":"78","author":"PJ Norris","year":"2004","unstructured":"Norris PJ, Moffett HF, Yang OO, Kaufmann DE, Clark MJ, Addo MM, et al. Beyond help:: Direct effector functions of human immunodeficiency virus type 1-specific CD4 T cells. J Virol. 2004;78(16):8844\u201351. https:\/\/doi.org\/10.1128\/Jvi.78.16.8844-8851.2004.","journal-title":"J Virol"},{"issue":"6","key":"773_CR23","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1182\/blood-2003-08-2765","volume":"103","author":"JJ Zaunders","year":"2004","unstructured":"Zaunders JJ, Dyer WB, Wang B, Munier ML, Miranda-Saksena M, Newton R, et al. Identification of Circulating antigen-specific CD4 T lymphocytes with a CCR5, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood. 2004;103(6):2238\u201347. https:\/\/doi.org\/10.1182\/blood-2003-08-2765. PubMed PMID: WOS:000220123400043.","journal-title":"Blood"},{"issue":"5","key":"773_CR24","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1182\/blood-2005-01-0206","volume":"106","author":"JJ Zaunders","year":"2005","unstructured":"Zaunders JJ, Munier ML, Kaufmann DE, Ip S, Grey P, Smith D, et al. Early proliferation of CCR5 CD38 antigen-specific CD4 Th1 effector cells during primary HIV-1 infection. Blood. 2005;106(5):1660\u20137. https:\/\/doi.org\/10.1182\/blood-2005-01-0206.","journal-title":"Blood"},{"issue":"7","key":"773_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/QAD.0b013e328337b144","volume":"24","author":"E Nemes","year":"2010","unstructured":"Nemes E, Bertoncelli L, Lugli E, Pinti M, Nasi M, Manzini L, et al. Cytotoxic granule release dominates gag-specific CD4 T-cell response in different phases of HIV infection. AIDS. 2010;24(7):947\u201357. https:\/\/doi.org\/10.1097\/QAD.0b013e328337b144.","journal-title":"AIDS"},{"issue":"15","key":"773_CR26","doi-asserted-by":"publisher","first-page":"7494","DOI":"10.1128\/JVI.00438-15","volume":"89","author":"S Johnson","year":"2015","unstructured":"Johnson S, Eller M, Teigler JE, Maloveste SM, Schultz BT, Soghoian DZ, et al. Cooperativity of HIV-specific cytolytic CD4 T cells and CD8 T cells in control of HIV viremia. J Virol. 2015;89(15):7494\u2013505 (PubMed PMID: WOS:000358277800006).","journal-title":"J Virol"},{"issue":"123","key":"773_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003165","volume":"4","author":"DZ Soghoian","year":"2012","unstructured":"Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med. 2012;4(123):123ra25. https:\/\/doi.org\/10.1126\/scitranslmed.3003165.","journal-title":"Sci Transl Med"},{"key":"773_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00012-17","author":"NW Cummins","year":"2017","unstructured":"Cummins NW, Sainski-Nguyen AM, Natesampillai S, Aboulnasr F, Kaufmann S, Badley AD. Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition. J Virol. 2017. https:\/\/doi.org\/10.1128\/jvi.00012-17.","journal-title":"J Virol"},{"issue":"1","key":"773_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/COH.0b013e3282f331b0","volume":"3","author":"S Mehandru","year":"2008","unstructured":"Mehandru S, Dandekar S. Role of the gastrointestinal tract in establishing infection in primates and humans. Curr Opin HIV AIDS. 2008;3(1):22\u20137. https:\/\/doi.org\/10.1097\/COH.0b013e3282f331b0.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"773_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/mi.2007.1","volume":"1","author":"JM Brenchley","year":"2008","unstructured":"Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1(1):23\u201330. https:\/\/doi.org\/10.1038\/mi.2007.1.","journal-title":"Mucosal Immunol"},{"issue":"6","key":"773_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4\u2009+\u2009T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200(6):749\u201359. https:\/\/doi.org\/10.1084\/jem.20040874.","journal-title":"J Exp Med"},{"issue":"1","key":"773_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20081242","volume":"206","author":"F Cruz-Guilloty","year":"2009","unstructured":"Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med. 2009;206(1):51\u20139. https:\/\/doi.org\/10.1084\/jem.20081242.","journal-title":"J Exp Med"},{"key":"773_CR33","doi-asserted-by":"crossref","unstructured":"Wei Y, Davenport TC, Collora JA, Ma HK, Pinto-Santini D, Lama J et al. Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence. Immunity. 2023;56(11):2584\u2009\u2013\u2009601 e7. Epub 20231102. doi: 10.1016\/j.immuni.2023.10.002. PubMed PMID: 37922905; PubMed Central PMCID: PMCPMC10843106.","DOI":"10.1016\/j.immuni.2023.10.002"},{"issue":"3","key":"773_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ni.2523","volume":"14","author":"D Mucida","year":"2013","unstructured":"Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R, Naoe Y, et al. Transcriptional reprogramming of mature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol. 2013;14(3):281\u20139. https:\/\/doi.org\/10.1038\/ni.2523.","journal-title":"Nat Immunol"},{"issue":"11","key":"773_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113429","volume":"42","author":"P Devarajan","year":"2023","unstructured":"Devarajan P, Vong AM, Castonguay CH, Silverstein NJ, Kugler-Umana O, Bautista BL, et al. Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I IFN-induced IL-15. Cell Rep. 2023;42(11):113429. https:\/\/doi.org\/10.1016\/j.celrep.2023.113429.","journal-title":"Cell Rep"},{"issue":"1","key":"773_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20150519","volume":"213","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi A, Badr Mel S, Miyauchi K, Ishihara C, Onishi R, Guo Z, et al. CRTAM determines the CD4\u2009+\u2009cytotoxic T lymphocyte lineage. J Exp Med. 2016;213(1):123\u201338. https:\/\/doi.org\/10.1084\/jem.20150519. Epub 20151222.","journal-title":"J Exp Med"},{"issue":"21","key":"773_CR37","doi-asserted-by":"publisher","first-page":"11884","DOI":"10.1128\/JVI.01461-13","volume":"87","author":"L Hua","year":"2013","unstructured":"Hua L, Yao S, Pham D, Jiang L, Wright J, Sawant D, et al. Cytokine-dependent induction of CD4\u2009+\u2009T cells with cytotoxic potential during influenza virus infection. J Virol. 2013;87(21):11884\u201393. https:\/\/doi.org\/10.1128\/JVI.01461-13.","journal-title":"J Virol"},{"key":"773_CR38","doi-asserted-by":"crossref","unstructured":"Sledzinska A, Vila de Mucha M, Bergerhoff K, Hotblack A, Demane DF, Ghorani E et al. Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4(+) T Cells. Immunity. 2020;52(1):151\u2009\u2013\u200966 e6. Epub 20200107. doi: 10.1016\/j.immuni.2019.12.007. PubMed PMID: 31924474; PubMed Central PMCID: PMCPMC7369640.","DOI":"10.1016\/j.immuni.2019.12.007"},{"issue":"8","key":"773_CR39","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.4049\/jimmunol.0900845","volume":"183","author":"CW Ashley","year":"2009","unstructured":"Ashley CW, Baecher-Allan C. Cutting edge: responder T cells regulate human DR\u2009+\u2009effector regulatory T cell activity via granzyme B. J Immunol. 2009;183(8):4843\u20137. https:\/\/doi.org\/10.4049\/jimmunol.0900845.","journal-title":"J Immunol"},{"issue":"4","key":"773_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39(4):633\u201345. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.001.","journal-title":"Immunity"},{"key":"773_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1173956","volume":"14","author":"J Ouyang","year":"2023","unstructured":"Ouyang J, Yan J, Zhou X, Isnard S, Harypursat V, Cui H, et al. Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV. Front Immunol. 2023;14:1173956. https:\/\/doi.org\/10.3389\/fimmu.2023.1173956.","journal-title":"Front Immunol"},{"issue":"1","key":"773_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00050-12","volume":"26","author":"G Marchetti","year":"2013","unstructured":"Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev. 2013;26(1):2\u201318. doi: 10.1128\/CMR.00050-12. PubMed PMID: 23297256; PubMed Central PMCID: PMCPMC3553668.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"773_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006048","volume":"12","author":"AJ Ericsen","year":"2016","unstructured":"Ericsen AJ, Lauck M, Mohns MS, DiNapoli SR, Mutschler JP, Greene JM, et al. Microbial translocation and inflammation occur in hyperacute immunodeficiency virus infection and compromise host control of virus replication. PLoS Pathog. 2016;12(12):e1006048. https:\/\/doi.org\/10.1371\/journal.ppat.1006048.","journal-title":"PLoS Pathog"},{"issue":"5","key":"773_CR44","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41385-018-0032-5","volume":"11","author":"T Hensley-McBain","year":"2018","unstructured":"Hensley-McBain T, Berard AR, Manuzak JA, Miller CJ, Zevin AS, Polacino P, et al. Intestinal damage precedes mucosal immune dysfunction in SIV infection. Mucosal Immunol. 2018;11(5):1429\u201340. https:\/\/doi.org\/10.1038\/s41385-018-0032-5.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"773_CR45","doi-asserted-by":"publisher","first-page":"e1006226","DOI":"10.1371\/journal.ppat.1006226","volume":"13","author":"AC Yoder","year":"2017","unstructured":"Yoder AC, Guo K, Dillon SM, Phang T, Lee EJ, Harper MS, et al. The transcriptome of HIV-1 infected intestinal CD4\u2009+\u2009T cells exposed to enteric bacteria. PLoS Pathog. 2017;13(2):e1006226. https:\/\/doi.org\/10.1371\/journal.ppat.1006226. PubMed PMID: 28241075; PubMed Central PMCID: PMCPMC5344538.","journal-title":"PLoS Pathog"},{"issue":"1","key":"773_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2045852","volume":"14","author":"SM Dillon","year":"2022","unstructured":"Dillon SM, Mickens KL, Thompson TA, Cooper EH, Nesladek S, Christians AJ, et al. Granzyme B(+) CD4 T cells accumulate in the colon during chronic HIV-1 infection. Gut Microbes. 2022;14(1):2045852. https:\/\/doi.org\/10.1080\/19490976.2022.2045852.","journal-title":"Gut Microbes"},{"issue":"1","key":"773_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-022-00305-9","volume":"19","author":"T Zhang","year":"2022","unstructured":"Zhang T, Liu X, Zhao Y, Xu X, Liu Y, Wu X. Excessive IL-15 promotes cytotoxic CD4\u2009+\u2009CD28- T cell-mediated renal injury in lupus nephritis. Immun Ageing. 2022;19(1):50. https:\/\/doi.org\/10.1186\/s12979-022-00305-9.","journal-title":"Immun Ageing"},{"issue":"1","key":"773_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","volume":"37","author":"D Masopust","year":"2019","unstructured":"Masopust D, Soerens AG. Tissue-resident T cells and other resident leukocytes. Annu Rev Immunol. 2019;37(1):521\u201346. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053214.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"773_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41385-020-0315-5","volume":"14","author":"R Bartolom\u00e9-Casado","year":"2021","unstructured":"Bartolom\u00e9-Casado R, Landsverk OJB, Chauhan SK, S\u00e6tre F, Hagen KT, Yaqub S. <article-title update=\"added\">CD4+ t cells persist for years in the human small intestine and display a TH1 cytokine profile. Mucosal Immunol. 2021;14(2):402\u201310. https:\/\/doi.org\/10.1038\/s41385-020-0315-5.","journal-title":"Mucosal Immunol"},{"issue":"33","key":"773_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo5871","volume":"8","author":"S Yenyuwadee","year":"2022","unstructured":"Yenyuwadee S, Sanchez-Trincado Lopez JL, Shah R, Rosato PC, Boussiotis VA. The evolving role of tissue-resident memory T cells in infections and cancer. Sci Adv. 2022;8(33):eabo5871. https:\/\/doi.org\/10.1126\/sciadv.abo5871.","journal-title":"Sci Adv"},{"issue":"2","key":"773_CR51","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4049\/jimmunol.1200681","volume":"189","author":"SM Dillon","year":"2012","unstructured":"Dillon SM, Manuzak JA, Leone AK, Lee EJ, Rogers LM, McCarter MD, et al. HIV-1 infection of human intestinal lamina propria CD4\u2009+\u2009T cells in vitro is enhanced by exposure to commensal Escherichia coli. J Immunol. 2012;189(2):885\u201396. https:\/\/doi.org\/10.4049\/jimmunol.1200681.","journal-title":"J Immunol"},{"issue":"11","key":"773_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae486","volume":"3","author":"KL Mickens","year":"2024","unstructured":"Mickens KL, Dillon SM, Guo K, Thompson AN, Barrett BS, Wood C, et al. Death and survival of gut CD4 T cells following HIV-1 infection ex vivo. PNAS Nexus. 2024;3(11):pgae486. https:\/\/doi.org\/10.1093\/pnasnexus\/pgae486.","journal-title":"PNAS Nexus"},{"issue":"6","key":"773_CR53","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1074-7613(01)00158-3","volume":"14","author":"A Simmons","year":"2001","unstructured":"Simmons A, Aluvihare V, McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity. 2001;14(6):763\u201377. https:\/\/doi.org\/10.1016\/S1074-7613(01)00158-3.","journal-title":"Immunity"},{"issue":"2","key":"773_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110650","volume":"39","author":"AK Reuschl","year":"2022","unstructured":"Reuschl AK, Mesner D, Shivkumar M, Whelan MVX, Pallett LJ, Guerra-Assun\u00e7ao JA, et al. HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells. Cell Rep. 2022;39(2):110650. https:\/\/doi.org\/10.1016\/j.celrep.2022.110650.","journal-title":"Cell Rep"},{"issue":"3","key":"773_CR55","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01369-21","volume":"12","author":"H Bauby","year":"2021","unstructured":"Bauby H, Ward CC, Hugh-White R, Swanson CM, Schulz R, Goujon C, et al. HIV-1 Vpr induces widespread transcriptomic changes in CD4 T cells early postinfection. mBio. 2021;12(3):e01369-21. https:\/\/doi.org\/10.1128\/mBio.01369-21.","journal-title":"mBio"},{"issue":"10","key":"773_CR56","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1128\/jvi.77.10.5846-5854.2003","volume":"77","author":"A Jekle","year":"2003","unstructured":"Jekle A, Keppler OT, De Clercq E, Schols D, Weinstein M, Goldsmith MA. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol. 2003;77(10):5846\u201354. https:\/\/doi.org\/10.1128\/jvi.77.10.5846-5854.2003.","journal-title":"J Virol"},{"issue":"5","key":"773_CR57","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","volume":"143","author":"G Doitsh","year":"2010","unstructured":"Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML, et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010;143(5):789\u2013801. PubMed PMID: 21111238; PubMed Central PMCID: PMCPMC3026834.","journal-title":"Cell"},{"issue":"7484","key":"773_CR58","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505(7484):509\u201314. https:\/\/doi.org\/10.1038\/nature12940.","journal-title":"Nature"},{"key":"773_CR59","doi-asserted-by":"publisher","unstructured":"Dillon SM, Guo K, Castleman MJ, Santiago ML, Wilson CC. Quantifying HIV-1-Mediated Gut CD4\u2009+\u2009T Cell Death in the Lamina Propria Aggregate Culture (LPAC) Model. Bio-Protocol. 2020;10(2). https:\/\/doi.org\/10.21769\/BioProtoc.3486.","DOI":"10.21769\/BioProtoc.3486"},{"issue":"21","key":"773_CR60","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.0802203105","volume":"105","author":"BF Keele","year":"2008","unstructured":"Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. P Natl Acad Sci USA. 2008;105(21):7552\u20137. https:\/\/doi.org\/10.1073\/pnas.0802203105. PubMed PMID: WOS:000256378100040.","journal-title":"P Natl Acad Sci USA"},{"issue":"5","key":"773_CR61","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1128\/JVI.06157-11","volume":"86","author":"C Ochsenbauer","year":"2012","unstructured":"Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, et al. Generation of transmitted\/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol. 2012;86(5):2715\u201328. PubMed PMID: 22190722; PubMed Central PMCID: PMC3302286.","journal-title":"J Virol"},{"key":"773_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-4690-11-14","volume":"11","author":"AK Steele","year":"2014","unstructured":"Steele AK, Lee EJ, Manuzak JA, Dillon SM, Beckham JD, McCarter MD, et al. Microbial exposure alters HIV-1-induced mucosal CD4\u2009+\u2009T cell death pathways ex vivo. Retrovirology. 2014;11:14. https:\/\/doi.org\/10.1186\/1742-4690-11-14. PubMed PMID: 24495380; PubMed Central PMCID: PMC3922902.","journal-title":"Retrovirology"},{"issue":"707","key":"773_CR63","doi-asserted-by":"publisher","first-page":"eadg0873","DOI":"10.1126\/scitranslmed.adg0873","volume":"15","author":"A Geretz","year":"2023","unstructured":"Geretz A, Ehrenberg PK, Clifford RJ, Laliberte A, Prelli Bozzo C, Eiser D, et al. Single-cell transcriptomics identifies Prothymosin alpha restriction of HIV-1 in vivo. Sci Transl Med. 2023;15(707):eadg0873. https:\/\/doi.org\/10.1126\/scitranslmed.adg0873. Epub 2023\/08\/02.","journal-title":"Sci Transl Med"},{"key":"773_CR64","doi-asserted-by":"crossref","unstructured":"Collora JA, Liu R, Pinto-Santini D, Ravindra N, Ganoza C, Lama JR et al. Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones. Immunity. 2022;55(6):1013-31 e7. Epub 20220322. doi: 10.1016\/j.immuni.2022.03.004. PubMed PMID: 35320704; PubMed Central PMCID: PMCPMC9203927.","DOI":"10.1016\/j.immuni.2022.03.004"},{"key":"773_CR65","doi-asserted-by":"publisher","unstructured":"Frouard J, Telwatte S, Luo X, Elphick N, Thomas R, Arneson D et al. Hiv-Seq Reveals Global Host Gene Expression Differences between Hiv-Transcribing Cells from Viremic and Suppressed People with Hiv. bioRxiv. 2024. Epub 20241220. https:\/\/doi.org\/10.1101\/2024.12.17.629023. PubMed PMID: 39763963; PubMed Central PMCID: PMCPMC11702770.","DOI":"10.1101\/2024.12.17.629023"},{"issue":"6","key":"773_CR66","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1128\/Jvi.03428-13","volume":"88","author":"L Matrajt","year":"2014","unstructured":"Matrajt L, Younan PM, Kiem HP, Schiffer JT. The majority of CD4 T-Cell depletion during acute Simian-Human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells. J Virol. 2014;88(6):3202\u201312. https:\/\/doi.org\/10.1128\/Jvi.03428-13. PubMed PMID: WOS:000332126000014.","journal-title":"J Virol"},{"issue":"4","key":"773_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101098","volume":"297","author":"XY Luo","year":"2021","unstructured":"Luo XY, Mouquet H, Schwartz O, Greene WC. Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission. J Biol Chem. 2021;297(4):101098. https:\/\/doi.org\/10.1016\/j.jbc.2021.101098.","journal-title":"J Biol Chem"},{"issue":"1","key":"773_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-014-0036-1","volume":"15","author":"L Lin","year":"2014","unstructured":"Lin L, Couturier J, Yu XY, Medina MA, Kozinetz CA, Lewis DE. Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells. BMC Immunol. 2014;15(1):36. https:\/\/doi.org\/10.1186\/s12865-014-0036-1.","journal-title":"BMC Immunol"},{"issue":"11","key":"773_CR69","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","volume":"89","author":"WA Boivin","year":"2009","unstructured":"Boivin WA, Cooper DM, Hiebert PR, Granville DJ. Intracellular extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest. 2009;89(11):1195\u2013220. https:\/\/doi.org\/10.1038\/labinvest.2009.91. PubMed PMID: WOS:000271248200002.","journal-title":"Lab Invest"},{"key":"773_CR70","doi-asserted-by":"publisher","unstructured":"Weymar GHJ, Bar -On Y, Oliveira TY, Gaebler C, Ramos V, Hartweger H et al. Distinct gene expression by expanded clones of quiescent memory CD4 T cells harboring intact latent HIV-1 proviruses. Cell Reports. 2022;40(10). doi: ARTN 111311 https:\/\/doi.org\/10.1016\/j.celrep.2022.111311. PubMed PMID: WOS:000863301600008.","DOI":"10.1016\/j.celrep.2022.111311"},{"key":"773_CR71","doi-asserted-by":"publisher","unstructured":"Ulhuq FR, Mariano G. Bacterial pore-forming toxins. Microbiol (Reading). 2022;168(3). https:\/\/doi.org\/10.1099\/mic.0.001154. PubMed PMID: 35333704; PubMed Central PMCID: PMCPMC9558359.","DOI":"10.1099\/mic.0.001154"},{"issue":"1","key":"773_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.immuni.2014.12.028","volume":"42","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee S, Hooper LV. Antimicrobial defense of the intestine. Immunity. 2015;42(1):28\u201339. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.028.","journal-title":"Immunity"},{"issue":"1","key":"773_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20604-3","volume":"12","author":"S Hiroyasu","year":"2021","unstructured":"Hiroyasu S, Zeglinski MR, Zhao H, Pawluk MA, Turner CT, Kasprick A, et al. Granzyme B inhibition reduces disease severity in autoimmune blistering diseases. Nat Commun. 2021;12(1):302. https:\/\/doi.org\/10.1038\/s41467-020-20604-3.","journal-title":"Nat Commun"},{"issue":"6","key":"773_CR74","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/infdis\/jiz538","volume":"221","author":"TM Campos","year":"2020","unstructured":"Campos TM, Novais FO, Saldanha M, Costa R, Lordelo M, Celestino D, et al. Granzyme B produced by natural killer cells enhances inflammatory response and contributes to the immunopathology of cutaneous leishmaniasis. J Infect Dis. 2020;221(6):973\u201382. https:\/\/doi.org\/10.1093\/infdis\/jiz538. PubMed PMID: 31748808; PubMed Central PMCID: PMCPMC7050991.","journal-title":"J Infect Dis"},{"issue":"16","key":"773_CR75","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.1317347111","volume":"111","author":"AC Wensink","year":"2014","unstructured":"Wensink AC, Kemp V, Fermie J, Laorden MIG, van der Poll T, Hack CE, et al. Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes. Proc Natl Acad Sci USA. 2014;111(16):5974\u20139. https:\/\/doi.org\/10.1073\/pnas.1317347111.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"773_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molcel.2011.07.037","volume":"44","author":"IS Afonina","year":"2011","unstructured":"Afonina IS, Tynan GA, Logue SE, Cullen SP, Bots M, Luthi AU, et al. Granzyme B-dependent proteolysis acts as a switch to enhance the Proinflammatory activity of IL-1alpha. Mol Cell. 2011;44(2):265\u201378. PubMed PMID: 22017873; PubMed Central PMCID: PMCPMC3319689.","journal-title":"Mol Cell"},{"issue":"2","key":"773_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jdermsci.2010.05.004","volume":"59","author":"Y Omoto","year":"2010","unstructured":"Omoto Y, Yamanaka K, Tokime K, Kitano S, Kakeda M, Akeda T, et al. Granzyme B is a novel interleukin-18 converting enzyme. J Dermatol Sci. 2010;59(2):129\u201335. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.05.004.","journal-title":"J Dermatol Sci"},{"key":"773_CR78","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fimmu.2020.00574","volume":"11","author":"JA Matsubara","year":"2020","unstructured":"Matsubara JA, Tian Y, Cui JZ, Zeglinski MR, Hiroyasu S, Turner CT, et al. Retinal distribution and extracellular activity of granzyme B: a serine protease that degrades retinal pigment epithelial tight junctions and extracellular matrix proteins. Front Immunol. 2020;11:574 (PubMed PMID: 32318066; PubMed Central PMCID: PMCPMC7155911).","journal-title":"Front Immunol"},{"issue":"6","key":"773_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100123","volume":"103","author":"G Obasanmi","year":"2023","unstructured":"Obasanmi G, Zeglinski MR, Hardie E, Wilhelm AC, Turner CT, Hiroyasu S, et al. Granzyme B contributes to choroidal neovascularization and age-related macular degeneration through proteolysis of thrombospondin-1. Lab Invest. 2023;103(6):100123. https:\/\/doi.org\/10.1016\/j.labinv.2023.100123.","journal-title":"Lab Invest"},{"issue":"5","key":"773_CR80","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1084\/jem.181.5.1917","volume":"181","author":"M Irmler","year":"1995","unstructured":"Irmler M, Hertig S, MacDonald HR, Sadoul R, Becherer JD, Proudfoot A, et al. Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med. 1995;181(5):1917\u201322. https:\/\/doi.org\/10.1084\/jem.181.5.1917.","journal-title":"J Exp Med"},{"issue":"5","key":"773_CR81","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.immuni.2008.08.014","volume":"29","author":"SS Metkar","year":"2008","unstructured":"Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity. 2008;29(5):720\u201333 (PubMed PMID: 18951048).","journal-title":"Immunity"},{"issue":"9","key":"773_CR82","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/febs.13699","volume":"283","author":"M Sharma","year":"2016","unstructured":"Sharma M, Merkulova Y, Raithatha S, Parkinson LG, Shen Y, Cooper D, et al. Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1. FEBS J. 2016;283(9):1734\u201347. https:\/\/doi.org\/10.1111\/febs.13699.","journal-title":"FEBS J"},{"issue":"8061","key":"773_CR83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-025-08713-9","volume":"641","author":"CA Donado","year":"2025","unstructured":"Donado CA, Theisen E, Zhang F, Nathan A, Fairfield ML, Rupani KV, et al. Granzyme K activates the entire complement cascade. Nature. 2025;641(8061):211\u201321. https:\/\/doi.org\/10.1038\/s41586-025-08713-9.","journal-title":"Nature"},{"issue":"3","key":"773_CR84","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.4049\/jimmunol.1000430","volume":"185","author":"DA Anthony","year":"2010","unstructured":"Anthony DA, Andrews DM, Chow M, Watt SV, House C, Akira S, et al. A role for granzyme M in TLR4-driven inflammation and endotoxicosis. J Immunol. 2010;185(3):1794\u2013803. https:\/\/doi.org\/10.4049\/jimmunol.1000430.","journal-title":"J Immunol"},{"issue":"7","key":"773_CR85","doi-asserted-by":"publisher","first-page":"e2302","DOI":"10.1038\/cddis.2016.215","volume":"7","author":"F Souza-Fonseca-Guimaraes","year":"2016","unstructured":"Souza-Fonseca-Guimaraes F, Krasnova Y, Putoczki T, Miles K, MacDonald KP, Town L, et al. Granzyme M has a critical role in providing innate immune protection in ulcerative colitis. Cell Death Dis. 2016;7(7):e2302. https:\/\/doi.org\/10.1038\/cddis.2016.215. Epub 20160721.","journal-title":"Cell Death Dis"},{"issue":"7742","key":"773_CR86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner KM, Wang Z, Simonetti FR, Bender AM, Kwon KJ, Sengupta S, et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature. 2019;566(7742):120\u20135. https:\/\/doi.org\/10.1038\/s41586-019-0898-8.","journal-title":"Nature"},{"issue":"5341","key":"773_CR87","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295\u2013300. https:\/\/doi.org\/10.1126\/science.278.5341.1295.","journal-title":"Science"},{"issue":"6","key":"773_CR88","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4\u2009+\u2009T cells. Nat Med. 2003;9(6):727\u20138. https:\/\/doi.org\/10.1038\/nm880.","journal-title":"Nat Med"},{"issue":"31","key":"773_CR89","doi-asserted-by":"publisher","first-page":"18692","DOI":"10.1073\/pnas.2006816117","volume":"117","author":"FR Simonetti","year":"2020","unstructured":"Simonetti FR, White JA, Tumiotto C, Ritter KD, Cai M, Gandhi RT, et al. Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA. Proc Natl Acad Sci U S A. 2020;117(31):18692\u2013700. https:\/\/doi.org\/10.1073\/pnas.2006816117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"773_CR90","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","volume":"27","author":"LB Cohn","year":"2020","unstructured":"Cohn LB, Chomont N, Deeks SG. The biology of the HIV-1 latent reservoir and implications for cure strategies. Cell Host Microbe. 2020;27(4):519\u201330. https:\/\/doi.org\/10.1016\/j.chom.2020.03.014. PubMed PMID: 32272077; PubMed Central PMCID: PMCPMC7219958.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"773_CR91","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2022.06.002","volume":"43","author":"M Lichterfeld","year":"2022","unstructured":"Lichterfeld M, Gao C, Yu XG. An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection. Trends Immunol. 2022;43(8):608\u201316. https:\/\/doi.org\/10.1016\/j.it.2022.06.002.","journal-title":"Trends Immunol"},{"issue":"4","key":"773_CR92","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","volume":"21","author":"RA Pollack","year":"2017","unstructured":"Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, et al. Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape. Cell Host Microbe. 2017;21(4):494-506 e4. https:\/\/doi.org\/10.1016\/j.chom.2017.03.008.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"773_CR93","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41587-019-0206-z","volume":"37","author":"AT Satpathy","year":"2019","unstructured":"Satpathy AT, Granja JM, Yost KE, Qi Y, Meschi F, McDermott GP, et al. Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion. Nat Biotechnol. 2019;37(8):925\u201336. https:\/\/doi.org\/10.1038\/s41587-019-0206-z.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"773_CR94","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/COH.0000000000000964","volume":"20","author":"GQ Lee","year":"2025","unstructured":"Lee GQ. A daisy chain of inferences: the role of single-cell and single-genome proviral sequencing in characterizing HIV-1 reservoirs. Curr Opin HIV AIDS. 2025;20(5):512\u20137. https:\/\/doi.org\/10.1097\/COH.0000000000000964.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"773_CR95","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00655-25","volume":"16","author":"N Mbhele","year":"2025","unstructured":"Mbhele N, Chimukangara B, Tyers L, Maldarelli F, Redd AD. Advancements in single-cell techniques for examining the HIV reservoir: pathways to a cure. mBio. 2025;16(7):e0065525. https:\/\/doi.org\/10.1128\/mbio.00655-25.","journal-title":"mBio"},{"issue":"5","key":"773_CR96","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/COH.0000000000000809","volume":"18","author":"M Wong","year":"2023","unstructured":"Wong M, Wei Y, Ho YC. Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels. Curr Opin HIV AIDS. 2023;18(5):246\u201356. https:\/\/doi.org\/10.1097\/COH.0000000000000809.","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"773_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003834","volume":"9","author":"CA Spina","year":"2013","unstructured":"Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, et al. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4\u2009+\u2009T cells from aviremic patients. PLoS Pathog. 2013;9(12):e1003834. https:\/\/doi.org\/10.1371\/journal.ppat.1003834.","journal-title":"PLoS Pathog"},{"issue":"5","key":"773_CR98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","volume":"24","author":"K Barton","year":"2016","unstructured":"Barton K, Winckelmann A, Palmer S. HIV-1 reservoirs during suppressive therapy. Trends Microbiol. 2016;24(5):345\u201355. https:\/\/doi.org\/10.1016\/j.tim.2016.01.006.","journal-title":"Trends Microbiol"},{"issue":"2","key":"773_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2055-6640(20)30490-8","volume":"1","author":"DA Kulpa","year":"2015","unstructured":"Kulpa DA, Chomont N. HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide? J Virus Erad. 2015;1(2):59\u201366. https:\/\/doi.org\/10.1016\/S2055-6640(20)30490-8.","journal-title":"J Virus Erad"},{"issue":"2","key":"773_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006856","volume":"14","author":"LE Hogan","year":"2018","unstructured":"Hogan LE, Vasquez J, Hobbs KS, Hanhauser E, Aguilar-Rodriguez B, Hussien R, et al. Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4\u2009+\u2009T cells expressing CD30. PLoS Pathog. 2018;14(2):e1006856. https:\/\/doi.org\/10.1371\/journal.ppat.1006856.","journal-title":"PLoS Pathog"},{"issue":"7","key":"773_CR101","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/infdis\/jiz572","volume":"221","author":"CA Prator","year":"2020","unstructured":"Prator CA, Thanh C, Kumar S, Pan T, Peluso MJ, Bosch R, et al. Circulating CD30 CD4 T cells increase before human immunodeficiency virus rebound after analytical antiretroviral treatment interruption. J Infect Dis. 2020;221(7):1146\u201355. https:\/\/doi.org\/10.1093\/infdis\/jiz572.","journal-title":"J Infect Dis"},{"issue":"23","key":"773_CR102","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/bloodadvances.2018024364","volume":"2","author":"CC Wang","year":"2018","unstructured":"Wang CC, Thanh C, Gibson EA, Ball-Burack M, Hogan LE, Descours B, et al. Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. Blood Adv. 2018;2(23):3479\u201382. https:\/\/doi.org\/10.1182\/bloodadvances.2018024364.","journal-title":"Blood Adv"},{"key":"773_CR103","doi-asserted-by":"crossref","unstructured":"Kuo HH, Ahmad R, Lee GQ, Gao C, Chen HR, Ouyang Z, et al. Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4(+) T Cells. Immunity. 2018;48(6):1183. 004. PubMed PMID: 29802019; PubMed Central PMCID: PMCPMC6013384. 94 e5.","DOI":"10.1016\/j.immuni.2018.04.004"},{"issue":"8","key":"773_CR104","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.4049\/jimmunol.0901514","volume":"183","author":"DR Withers","year":"2009","unstructured":"Withers DR, Jaensson E, Gaspal F, McConnell FM, Eksteen B, Anderson G, et al. The survival of memory CD4\u2009+\u2009T cells within the gut lamina propria requires OX40 and CD30 signals. J Immunol. 2009;183(8):5079\u201384. https:\/\/doi.org\/10.4049\/jimmunol.0901514.","journal-title":"J Immunol"},{"issue":"2","key":"773_CR105","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/blood.V90.2.745","volume":"90","author":"F Hashimoto","year":"1997","unstructured":"Hashimoto F, Oyaizu N, Kalyanaraman VS, Pahwa S. Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood. 1997;90(2):745\u201353. PubMed PMID: 9226175.","journal-title":"Blood"},{"issue":"18","key":"773_CR106","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.93.18.9571","volume":"93","author":"PR Strack","year":"1996","unstructured":"Strack PR, Frey MW, Rizzo CJ, Cordova B, George HJ, Meade R, et al. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc Natl Acad Sci U S A. 1996;93(18):9571\u20136. https:\/\/doi.org\/10.1073\/pnas.93.18.9571.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"773_CR107","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4.","journal-title":"Cell Death Differ"},{"issue":"8","key":"773_CR108","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1128\/Jvi.03179-15","volume":"90","author":"NW Cummins","year":"2016","unstructured":"Cummins NW, Sainski AM, Dai H, Natesampillai S, Pang YP, Bren GD, et al. Prime, shock, and kill: priming CD4 T cells from HIV patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size. J Virol. 2016;90(8):4032\u201348. https:\/\/doi.org\/10.1128\/Jvi.03179-15.","journal-title":"J Virol"},{"issue":"10","key":"773_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008906","volume":"16","author":"AJ French","year":"2020","unstructured":"French AJ, Natesampillai S, Krogman A, Correia C, Peterson KL, Alto A, et al. Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2. PLoS Pathog. 2020;16(10):e1008906. https:\/\/doi.org\/10.1371\/journal.ppat.1008906.","journal-title":"PLoS Pathog"},{"issue":"4","key":"773_CR110","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.immuni.2017.09.018","volume":"47","author":"CS McGary","year":"2017","unstructured":"McGary CS, Deleage C, Harper J, Micci L, Ribeiro SP, Paganini S, et al. CTLA-4 PD-1 memory CD4 T cells critically contribute to viral persistence in antiretroviral therapy-suppressed, SIV-infected rhesus macaques. Immunity. 2017;47(4):776. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.018.","journal-title":"Immunity"},{"issue":"2","key":"773_CR111","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1172\/jci97555","volume":"128","author":"SH Huang","year":"2018","unstructured":"Huang SH, Ren Y, Thomas AS, Chan D, Mueller S, Ward AR, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8\u2009+\u2009T cells. J Clin Invest. 2018;128(2):876\u201389. https:\/\/doi.org\/10.1172\/jci97555.","journal-title":"J Clin Invest"},{"key":"773_CR112","doi-asserted-by":"crossref","unstructured":"Herrera A, Leyre L, Weiler J, Linden NL, Huynh TT, Wang F et al. Multi-Omic Atlas reveals cytotoxic phenotype and ROS-linked metabolic quiescence as key features of CTL-resistant HIV-infected CD4 (+) T-cells. bioRxiv. 2024. Epub 20241223. doi: 10.1101\/2024.12.22.629960. PubMed PMID: 39763858; PubMed Central PMCID: PMCPMC11702756.","DOI":"10.1101\/2024.12.22.629960"},{"issue":"5","key":"773_CR113","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1172\/Jci132374","volume":"130","author":"YQ Ren","year":"2020","unstructured":"Ren YQ, Huang SH, Patel S, Alberto WDC, Magat D, Ahimovic D, et al. BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo. J Clin Invest. 2020;130(5):2542\u201359. https:\/\/doi.org\/10.1172\/Jci132374.","journal-title":"J Clin Invest"},{"issue":"9","key":"773_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101178","volume":"4","author":"P Arandjelovic","year":"2023","unstructured":"Arandjelovic P, Kim Y, Cooney JP, Preston SP, Doerflinger M, Mcmahon JH, et al. Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice. Cell Rep Med. 2023;4(9):101178. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101178.","journal-title":"Cell Rep Med"},{"key":"773_CR115","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-7060088\/v1","author":"TRW Salinas","year":"2025","unstructured":"Salinas TRW, Harper J, Deleage C, Nguyen K, Auger J, Flores HR, et al. BCL-2 Inhibition via venetoclax at ART initiation induces Long-Term reduction of the intact SIV reservoir. Res Sq. 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-7060088\/v1. Epub 20250714.","journal-title":"Res Sq"},{"key":"773_CR116","unstructured":"Rasmussen TAL. S. A. Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART (AMBER) 2024 [cited 2025 25 April]. NCT05668026]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05668026?cond=hiv-1&term=venetoclax&rank=1"},{"issue":"2","key":"773_CR117","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41590-022-01371-3","volume":"24","author":"VH Wu","year":"2023","unstructured":"Wu VH, Nordin JML, Nguyen S, Joy J, Mampe F, Del Rio Estrada PM, et al. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4(+) T cell reservoir. Nat Immunol. 2023;24(2):359\u201370. https:\/\/doi.org\/10.1038\/s41590-022-01371-3.","journal-title":"Nat Immunol"},{"issue":"11","key":"773_CR118","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes JD, Kityo C, Ssali F, Swainson L, Makamdop KN, Del Prete GQ, et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat Med. 2017;23(11):1271\u20136. https:\/\/doi.org\/10.1038\/nm.4411.","journal-title":"Nat Med"},{"issue":"10","key":"773_CR119","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1086\/656722","volume":"202","author":"SA Yukl","year":"2010","unstructured":"Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, Duan L, et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis. 2010;202(10):1553\u201361. https:\/\/doi.org\/10.1086\/656722.","journal-title":"J Infect Dis"},{"key":"773_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112603","author":"J Medler","year":"2022","unstructured":"Medler J, Kucka K, Wajant H. Tumor necrosis factor receptor 2 (TNFR2): an emerging target in cancer therapy. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14112603.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"773_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05620-x","volume":"22","author":"L Li","year":"2024","unstructured":"Li L, Ye R, Li Y, Pan H, Han S, Lu Y. Targeting TNFR2 for cancer immunotherapy: recent advances and future directions. J Transl Med. 2024;22(1):812. https:\/\/doi.org\/10.1186\/s12967-024-05620-x.","journal-title":"J Transl Med"},{"issue":"11","key":"773_CR122","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm1101-1217","volume":"7","author":"D Wolf","year":"2001","unstructured":"Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med. 2001;7(11):1217\u201324. https:\/\/doi.org\/10.1038\/nm1101-1217.","journal-title":"Nat Med"},{"issue":"6830","key":"773_CR123","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/35071111","volume":"410","author":"R Geleziunas","year":"2001","unstructured":"Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature. 2001;410(6830):834\u20138. https:\/\/doi.org\/10.1038\/35071111.","journal-title":"Nature"},{"issue":"2","key":"773_CR124","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/AID.2019.0213","volume":"36","author":"AC Paim","year":"2020","unstructured":"Paim AC, Badley AD, Cummins NW. Mechanisms of human immunodeficiency virus-associated lymphocyte regulated cell death. AIDS Res Hum Retroviruses. 2020;36(2):101\u201315. https:\/\/doi.org\/10.1089\/AID.2019.0213.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"773_CR125","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jmii.2023.08.011","volume":"56","author":"I Rosado-S\u00e1nchez","year":"2023","unstructured":"Rosado-S\u00e1nchez I, Herrero-Fern\u00e1ndez I, Sobrino S, Carvajal AE, Genebat M, Taranc\u00f3n-D\u00edez L, et al. Caecum OX40DCD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection. J Microbiol Immunol Infect. 2023;56(6):1129\u201338. https:\/\/doi.org\/10.1016\/j.jmii.2023.08.011.","journal-title":"J Microbiol Immunol Infect"},{"key":"773_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.07.022","author":"Y Wei","year":"2025","unstructured":"Wei Y, Ma HK, Wong ME, Back H, Papasavvas E, Mounzer K, et al. Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence. Immunity. 2025. https:\/\/doi.org\/10.1016\/j.immuni.2025.07.022.","journal-title":"Immunity"},{"issue":"11","key":"773_CR127","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","volume":"168","author":"V Appay","year":"2002","unstructured":"Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, et al. Characterization of CD4 CTLs ex vivo. J Immunol. 2002;168(11):5954\u20138. https:\/\/doi.org\/10.4049\/jimmunol.168.11.5954.","journal-title":"J Immunol"},{"issue":"7","key":"773_CR128","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1182\/blood-2002-08-2502","volume":"101","author":"LE Gamadia","year":"2003","unstructured":"Gamadia LE, Remmerswaal EBM, Weel JF, Bemelman F, van Lier RAW, Ten Berge IJM. Primary immune responses to human CMV: a critical role for IFN-\u03b3-producing CD4 T cells in protection against CMV disease. Blood. 2003;101(7):2686\u201392. https:\/\/doi.org\/10.1182\/blood-2002-08-2502.","journal-title":"Blood"},{"issue":"13","key":"773_CR129","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1084\/jem.20052246","volume":"203","author":"JP Casazza","year":"2006","unstructured":"Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM, et al. Acquisition of direct antiviral effector functions by CMV-specific CD4\u2009+\u2009T lymphocytes with cellular maturation. J Exp Med. 2006;203(13):2865\u201377. https:\/\/doi.org\/10.1084\/jem.20052246.","journal-title":"J Exp Med"},{"issue":"4","key":"773_CR130","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/ajt.13614","volume":"16","author":"S Shabir","year":"2016","unstructured":"Shabir S, Smith H, Kaul B, Pachnio A, Jham S, Kuravi S, et al. <article-title update=\"added\">Cytomegalovirus-associated CD4+CD28null cells in NKG2D-dependent glomerular endothelial injury and kidney allograft dysfunction. Am J Transplant. 2016;16(4):1113\u201328. https:\/\/doi.org\/10.1111\/ajt.13614.","journal-title":"Am J Transplant"},{"issue":"1","key":"773_CR131","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4049\/jimmunol.1403039","volume":"196","author":"I Akhmetzyanova","year":"2016","unstructured":"Akhmetzyanova I, Zelinskyy G, Littwitz-Salomon E, Malyshkina A, Dietze KK, Streeck H, et al. CD137 agonist therapy can reprogram regulatory T cells into cytotoxic CD4 T cells with antitumor activity. J Immunol. 2016;196(1):484\u201392. https:\/\/doi.org\/10.4049\/jimmunol.1403039.","journal-title":"J Immunol"},{"issue":"11","key":"773_CR132","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.vaccine.2010.12.029","volume":"29","author":"X Zhou","year":"2011","unstructured":"Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A\/H3N2 and pandemic A\/H1N1 strains in humans. Vaccine. 2011;29(11):2169\u201377. PubMed PMID: WOS:000288731000026.","journal-title":"Vaccine"},{"issue":"44","key":"773_CR133","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1016\/j.vaccine.2016.09.009","volume":"34","author":"CML Munier","year":"2016","unstructured":"Munier CML, van Bockel D, Bailey M, Ip S, Xu Y, Alcantara S, et al. The primary immune response to vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype. Vaccine. 2016;34(44):5251\u201361. https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.009. PubMed PMID: WOS:000386322600006.","journal-title":"Vaccine"},{"issue":"10","key":"773_CR134","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.4049\/jimmunol.162.10.6100","volume":"162","author":"M Yasukawa","year":"1999","unstructured":"Yasukawa M, Ohminami H, Yakushijin Y, Arai J, Hasegawa A, Ishida Y, et al. Fas-independent cytotoxicity mediated by human CD4 CTL directed against herpes simplex virus-infected cells. J Immunol. 1999;162(10):6100\u20136. PubMed PMID: WOS:000080240200059.","journal-title":"J Immunol"},{"issue":"8","key":"773_CR135","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","volume":"13","author":"N Aslan","year":"2006","unstructured":"Aslan N, Yurdaydin C, Wiegand J, Greten T, Ciner A, Meyer MF, et al. Cytotoxic CD4 T cells in viral hepatitis. J Viral Hepat. 2006;13(8):505\u201314. https:\/\/doi.org\/10.1111\/j.1365-2893.2006.00723.x.","journal-title":"J Viral Hepat"},{"issue":"5","key":"773_CR136","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1128\/Jvi.73.5.3623-3629.1999","volume":"73","author":"SJ Gagnon","year":"1999","unstructured":"Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4 cytotoxic T-lymphocyte clones. J Virol. 1999;73(5):3623\u20139. https:\/\/doi.org\/10.1128\/Jvi.73.5.3623-3629.1999.","journal-title":"J Virol"},{"key":"773_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.13","author":"A Kumar","year":"2015","unstructured":"Kumar A, Perdomo MF, Kantele A, Hedman L, Hedman K, Franssila R. Granzyme B mediated function of Parvovirus B19-specific CD4 T cells. Clin Transl Immunol. 2015. https:\/\/doi.org\/10.1038\/cti.2015.13.","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"773_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004788","volume":"11","author":"Y Ma","year":"2015","unstructured":"Ma Y, Yuan B, Zhuang R, Zhang YS, Liu B, Zhang CM, et al. Hantaan virus infection induces both Th1 and ThGranzyme B+ cell immune responses that associated with viral control and clinical outcome in humans. PLoS Pathog. 2015;11(4):e1004788. https:\/\/doi.org\/10.1371\/journal.ppat.1004788.","journal-title":"PLoS Pathog"},{"issue":"1","key":"773_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-015-0190-7","volume":"22","author":"M Garcia-Chagollan","year":"2015","unstructured":"Garcia-Chagollan M, Jave-Suarez LF, Haramati J, Bueno-Topete MR, Aguilar-Lemarroy A, Estrada-Chavez C, et al. An approach to the immunophenotypic features of circulating CD4 NKG2D T cells in invasive cervical carcinoma. J Biomed Sci. 2015;22(1):91. https:\/\/doi.org\/10.1186\/s12929-015-0190-7.","journal-title":"J Biomed Sci"},{"key":"773_CR140","first-page":"623","volume":"109","author":"XY Guo","year":"2018","unstructured":"Guo XY, Zhang YY, Zheng LT, Zhang ZM. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Cancer Sci. 2018;109:623. PubMed PMID: WOS:000453773603047.","journal-title":"Cancer Sci"},{"issue":"7735","key":"773_CR141","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu X, Zheng LT, Zhang YY, Li YS, Fang Q, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564(7735):268. https:\/\/doi.org\/10.1038\/s41586-018-0694-x.","journal-title":"Nature"},{"issue":"7","key":"773_CR142","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"CH Zheng","year":"2017","unstructured":"Zheng CH, Zheng LT, Yoo JK, Guo HH, Zhang YY, Guo XY, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342. https:\/\/doi.org\/10.1016\/j.cell.2017.05.035.","journal-title":"Cell"},{"key":"773_CR143","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.annonc.2021.03.049","volume":"32","author":"KS Shohdy","year":"2021","unstructured":"Shohdy KS, Almeldin DS, Ghaly R, Kassem L, Pagani O. 35P prognostic impact of cytotoxic CD4 T cells (CD4 CTL) in tumour immune microenvironment of breast cancer patients. Ann Oncol. 2021;32:S34\u20135. https:\/\/doi.org\/10.1016\/j.annonc.2021.03.049.","journal-title":"Ann Oncol"},{"issue":"9","key":"773_CR144","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3348","volume":"7","author":"A Cachot","year":"2021","unstructured":"Cachot A, Bilous M, Liu YC, Li XK, Saillard M, Cenerenti M, et al. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer. Sci Adv. 2021;7(9):eabe3348. https:\/\/doi.org\/10.1126\/sciadv.abe3348.","journal-title":"Sci Adv"},{"issue":"1","key":"773_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20059-6","volume":"11","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yang D, Yang QB, Lv XB, Huang WT, Zhou ZH, et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun. 2020;11(1):6322. https:\/\/doi.org\/10.1038\/s41467-020-20059-6.","journal-title":"Nat Commun"},{"key":"773_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.017","author":"DY Oh","year":"2020","unstructured":"Oh DY, Kwek SS, Raju SS, Li T, McCarthy E, Chow E, et al. Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell. 2020;181(7):1612. https:\/\/doi.org\/10.1016\/j.cell.2020.05.017. Epub 20200603. 25 e13."},{"issue":"3","key":"773_CR147","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1074\/mcp.M115.050138","volume":"15","author":"T Riaz","year":"2016","unstructured":"Riaz T, Sollid LM, Olsen I, de Souza GA. Quantitative proteomics of gut-derived Th1 and Th1\/Th17 clones reveal the presence of CD28\u2009+\u2009NKG2D-Th1 cytotoxic CD4\u2009+\u2009T cells. Mol Cell Proteomics. 2016;15(3):1007\u201316. https:\/\/doi.org\/10.1074\/mcp.M115.050138.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"773_CR148","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.gastro.2011.03.061","volume":"141","author":"B Pariente","year":"2011","unstructured":"Pariente B, Mocan I, Camus M, Dutertre CA, Ettersperger J, Cattan P, et al. Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4\u2009+\u2009T cells of patients with crohn\u2019s disease. Gastroenterology. 2011;141(1):217\u2013U301. https:\/\/doi.org\/10.1053\/j.gastro.2011.03.061. PubMed PMID: WOS:000292299700043.","journal-title":"Gastroenterology"},{"issue":"3","key":"773_CR149","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ni.2518","volume":"14","author":"BS Reis","year":"2013","unstructured":"Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I, Mucida D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4 T cell immunity. Nat Immunol. 2013;14(3):271\u201380. https:\/\/doi.org\/10.1038\/ni.2518.","journal-title":"Nat Immunol"},{"issue":"1","key":"773_CR150","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2011.11.006","volume":"38","author":"B Broux","year":"2012","unstructured":"Broux B, Pannemans K, Zhang X, Markovic-Plese S, Broekmans T, Eijnde BO, et al. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. J Autoimmun. 2012;38(1):10\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2011.11.006.","journal-title":"J Autoimmun"},{"issue":"8","key":"773_CR151","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.molmed.2012.06.003","volume":"18","author":"B Broux","year":"2012","unstructured":"Broux B, Markovic-Plese S, Stinissen P, Hellings N. Pathogenic features of CD4\u2009+\u2009CD28- T cells in immune disorders. Trends Mol Med. 2012;18(8):446\u201353. https:\/\/doi.org\/10.1016\/j.molmed.2012.06.003.","journal-title":"Trends Mol Med"},{"issue":"5","key":"773_CR152","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/hc0502.103348","volume":"105","author":"T Nakajima","year":"2002","unstructured":"Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002;105(5):570\u20135. https:\/\/doi.org\/10.1161\/hc0502.103348.","journal-title":"Circulation"},{"issue":"8","key":"773_CR153","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.4049\/jimmunol.181.8.5233","volume":"181","author":"B Zal","year":"2008","unstructured":"Zal B, Kaski JC, Akiyu JP, Cole D, Arno G, Poloniecki J, et al. Differential pathways govern CD4 CD28 T cell proinflammatory and effector responses in patients with coronary artery disease. J Immunol. 2008;181(8):5233\u201341. https:\/\/doi.org\/10.4049\/jimmunol.181.8.5233.","journal-title":"J Immunol"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-026-00773-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00773-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:09:32Z","timestamp":1771430972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-026-00773-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s11904-026-00773-4","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.cell.2020.05.017","asserted-by":"subject"}]},"ISSN":["1548-3576"],"issn-type":[{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}